research use only

(+)-Catechin Antioxidant chemical

Cat.No.S4722

(+)-Catechin (Cianidanol, Catechinic acid, Catechuic acid) is an antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms.,
Jump to

Quality Control

Batch: Purity: 99.79%
99.79

Solubility

In vitro
Batch:

DMSO : 58 mg/mL (199.81 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 58 mg/mL

Water : 1.8 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 290.27 Formula

C15H14O6

Storage (From the date of receipt) 3 years -20°C powder (seal)
CAS No. 154-23-4 Download SDF Storage of Stock Solutions Solutions are unstable. Prepare fresh or purchase small, pre-packaged sizes. Repackage upon receipt.
Synonyms Cianidanol, Catechinic acid, Catechuic acid, Catechin SMILES C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O

Read more about storage stability CAS number SMILES

Mechanism of Action

Targets/IC50/Ki
COX-1
(Cell-based assay)
80 μM
COX-2
(Cell-based assay)
130 μM
In vitro
The catechin flavonoid reduces proliferation and induces apoptosis of murine lymphoma cells LB02 through modulation of antiapoptotic proteins. Treatment of human prostate cancer cells with catechin induces apoptosis and results in effects on a variety of survival signals suggesting the potential of these compounds as chemopreventive agents for prostate cancer. Catechin is well known to inhibit cyclooxygenase activity with reported IC50 values ranging from 4O μM to 943 μM. It has also been reported to act as an inhibitor of COX-1 and COX-2 with IC50 of about 80 µM and 130 μM.
In vivo
Dietary catechin significantly delayed tumor onset. Continued intake of catechin, a potential antioxidant, prevents memory regression and DNA oxidative damage in senescence-accelerated (SAMP10) mice. It does not prolong the lifetime of SAMP10 mice, but it does delay brain senescence. (+)-Catechin inhibits intestinal tumor formation and suppresses Focal adhesion kinase activation in the Min/+ Mouse.
References
  • [4] https://pubmed.ncbi.nlm.nih.gov/8187052/
  • [5] https://pubmed.ncbi.nlm.nih.gov/12324302/
  • [6] https://pubmed.ncbi.nlm.nih.gov/16957869/
  • [7] http://cancerres.aacrjournals.org/content/canres/61/1/118.full.pdf

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2025-09-05)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06015022 RECRUITING
Cirrhosis, Liver
University of Texas Southwestern Medical Center
2024-09-01 PHASE2
NCT07161726 RECRUITING
Mobility Disability
University of Alabama at Birmingham
2026-04-21 PHASE1; PHASE2
NCT04300855 ACTIVE_NOT_RECRUITING
Prostate Cancer; Prostate Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute
2020-08-21 PHASE2
NCT04597359 ACTIVE_NOT_RECRUITING
Prostate Carcinoma
ECOG-ACRIN Cancer Research Group
2021-10-05 PHASE2
NCT07149506 ENROLLING_BY_INVITATION
Radiation Dermatitis Acute; Radiation Dermatitis; Fibrosis; Skin
CARLOS FRANCISCO SAAVEDRA GARCIA
2025-09-01 PHASE3
NCT06631820 RECRUITING
Chronic Kidney Disease(CKD); Myosteatosis; Mitochondrial Dysfunction; Muscle Function; Muscle Mass
Karolinska Institutet
2025-01-17

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.